Screening for sight threatening eye disease. Cost effectiveness of screening modalities must be determined.
Adab
P
P
D003362:Cost-Benefit Analysis; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D006801:Humans; D015351:Vision Screening / Q000191:economics*